A Randomized, Double-Masked, Active-Controlled, Crossover Phase III Equivalence Study of Generic Dorzolamide 2% versus Innovator Trusopt® Eye Drop Solution in Subjects with Open-Angle Glaucoma or Ocular Hypertension.
Katharina BellChristina A KorbChristina ButschBert Constantin GiersAnna BeckAlicja StrzalkowskaChristian RuckesUlrike KlingbergNorbert PfeifferKatrin LorenzPublished in: Journal of ophthalmology (2022)
This trial is registered with (ClinicalTrials.gov (identifier: NCT00878917) on April 9, 2009).